Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
Analysts expect modest revenue growth but pressure on profitability in the March quarter
PMDA is regarded among the most stringent regulatory bodies globally
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
The company allocated €56 million to research and development for next-generation line solutions
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs
Subscribe To Our Newsletter & Stay Updated
